| Business Summary | | Paracelsian,
Inc.
is
a
development
stage
company
that
develops
and
applies
bioassays
to
monitor
environmental
toxins,
determine
the
quality
of
herbal
products
and
identify
therapeutic
compounds
from
herbal
sources.
The
Company
has
developed
specific
need-driven
bioassay
systems
for
three
markets,
including
environmental
testing
(Ah-IMMUNOASSAY
Kit),
herbal
supplements
(BioFIT
Quality
Assurance
Program)
and
drug
discovery
and
development
(Drug
Screening
Assay
System).
The
Company
is
also
engaged
in
an
Internet-based
health
exchange
between
the
United
States
and
China
and
maintains
the
Website
www.newcenturynutrition.com. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Paracelsian
is
a
development
stage
bioscience
and
technology
company
that
utilizes
its
proprietary
screening
technology
to
identify
novel
therapeutic
compounds
from
herbal
sources.
For
the
six
months
ended
3/31/01,
net
sales
fell
19%
to
$136
thousand.
Net
loss
fell
18%
to
$573
thousand.
Revenues
reflect
lower
product
testing
income.
Lower
loss
reflects
lower
SG&A
expenses
and
a
decrease
in
research
and
product
engineering
expenses. | More
from
Market Guide: Significant
Developments |
| | |
| Position | T. Colin Campbell, 66 | Chairman | Noriyoshi Inoue, 53 | Pres,
CEO, Director |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|